Novelix Pharma to hold EGM for Preferential Issue

Novelix Pharmaceuticals Ltd. (formerly Trimurti Limited) has announced an Extra Ordinary General Meeting (EGM) scheduled for July 01, 2026, to be held via Video Conferencing. The primary agenda item is to consider and approve the issue of up to 12,00,000 equity shares on a preferential basis. These shares will be offered at an issue price of ₹57 each, comprising a face value of ₹10 and a premium of ₹47 per share. The meeting will also seek approval for related regulatory compliances under various sections of the Companies Act, 2013, and SEBI regulations.